The Malaysian Reserve

European Commission Approves BRINSUPRI® (brensocatib) as the First and Only Treatment To ...

BRINSUPRI (brensocatib) is a small molecule, once-daily, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1). In the ...